364 related articles for article (PubMed ID: 29789882)
1. Rapid development of stable transgene CHO cell lines by CRISPR/Cas9-mediated site-specific integration into C12orf35.
Zhao M; Wang J; Luo M; Luo H; Zhao M; Han L; Zhang M; Yang H; Xie Y; Jiang H; Feng L; Lu H; Zhu J
Appl Microbiol Biotechnol; 2018 Jul; 102(14):6105-6117. PubMed ID: 29789882
[TBL] [Abstract][Full Text] [Related]
2. Targeted integration into pseudo attP sites of CHO cells using CRISPR/Cas9.
Pourtabatabaei S; Ghanbari S; Damavandi N; Bayat E; Raigani M; Zeinali S; Davami F
J Biotechnol; 2021 Aug; 337():1-7. PubMed ID: 34157351
[TBL] [Abstract][Full Text] [Related]
3. Controlling Ratios of Plasmid-Based Double Cut Donor and CRISPR/Cas9 Components to Enhance Targeted Integration of Transgenes in Chinese Hamster Ovary Cells.
Shin SW; Kim D; Lee JS
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673701
[TBL] [Abstract][Full Text] [Related]
4. Targeted knock-in of an scFv-Fc antibody gene into the hprt locus of Chinese hamster ovary cells using CRISPR/Cas9 and CRIS-PITCh systems.
Kawabe Y; Komatsu S; Komatsu S; Murakami M; Ito A; Sakuma T; Nakamura T; Yamamoto T; Kamihira M
J Biosci Bioeng; 2018 May; 125(5):599-605. PubMed ID: 29295784
[TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9 as a Genome Editing Tool for Targeted Gene Integration in CHO Cells.
Sergeeva D; Camacho-Zaragoza JM; Lee JS; Kildegaard HF
Methods Mol Biol; 2019; 1961():213-232. PubMed ID: 30912048
[TBL] [Abstract][Full Text] [Related]
6. Accelerated homology-directed targeted integration of transgenes in Chinese hamster ovary cells via CRISPR/Cas9 and fluorescent enrichment.
Lee JS; Grav LM; Pedersen LE; Lee GM; Kildegaard HF
Biotechnol Bioeng; 2016 Nov; 113(11):2518-23. PubMed ID: 27159230
[TBL] [Abstract][Full Text] [Related]
7. Site-specific integration in CHO cells mediated by CRISPR/Cas9 and homology-directed DNA repair pathway.
Lee JS; Kallehauge TB; Pedersen LE; Kildegaard HF
Sci Rep; 2015 Feb; 5():8572. PubMed ID: 25712033
[TBL] [Abstract][Full Text] [Related]
8. Nanopore Cas9-targeted sequencing enables accurate and simultaneous identification of transgene integration sites, their structure and epigenetic status in recombinant Chinese hamster ovary cells.
Leitner K; Motheramgari K; Borth N; Marx N
Biotechnol Bioeng; 2023 Sep; 120(9):2403-2418. PubMed ID: 36938677
[TBL] [Abstract][Full Text] [Related]
9. Efficient site-specific integration in CHO-K1 cells using CRISPR/Cas9-modified donors.
Kheirandish MH; Rahmani B; Zarei Jaliani H; Barkhordari F; Mazlomi MA; Davami F
Mol Biol Rep; 2023 Jul; 50(7):5889-5899. PubMed ID: 37244887
[TBL] [Abstract][Full Text] [Related]
10. Novel CRISPR/Cas9-mediated knockout of LIG4 increases efficiency of site-specific integration in Chinese hamster ovary cell line.
Wang C; Sun Z; Wang M; Jiang Z; Zhang M; Cao H; Luo L; Qiao C; Xiao H; Chen G; Li X; Liu J; Wei Z; Shen B; Wang J; Feng J
Biotechnol Lett; 2022 Sep; 44(9):1063-1072. PubMed ID: 35918621
[TBL] [Abstract][Full Text] [Related]
11. CRISPR-Cas9 Mediated Stable Expression of Exogenous Proteins in the CHO Cell Line through Site-Specific Integration.
Huang Z; Habib A; Zhao G; Ding X
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069090
[TBL] [Abstract][Full Text] [Related]
12. A system for site-specific integration of transgenes in mammalian cells.
Chi X; Zheng Q; Jiang R; Chen-Tsai RY; Kong LJ
PLoS One; 2019; 14(7):e0219842. PubMed ID: 31344144
[TBL] [Abstract][Full Text] [Related]
13. CRISPR-interceded CHO cell line development approaches.
Amiri S; Adibzadeh S; Ghanbari S; Rahmani B; Kheirandish MH; Farokhi-Fard A; Dastjerdeh MS; Davami F
Biotechnol Bioeng; 2023 Apr; 120(4):865-902. PubMed ID: 36597180
[TBL] [Abstract][Full Text] [Related]
14. Accumulative scFv-Fc antibody gene integration into the hprt chromosomal locus of Chinese hamster ovary cells.
Wang X; Kawabe Y; Kato R; Hada T; Ito A; Yamana Y; Kondo M; Kamihira M
J Biosci Bioeng; 2017 Nov; 124(5):583-590. PubMed ID: 28662917
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9-mediated genome engineering of CHO cell factories: Application and perspectives.
Lee JS; Grav LM; Lewis NE; Faustrup Kildegaard H
Biotechnol J; 2015 Jul; 10(7):979-94. PubMed ID: 26058577
[TBL] [Abstract][Full Text] [Related]
16. Optimized CRISPR/Cas9 strategy for homology-directed multiple targeted integration of transgenes in CHO cells.
Shin SW; Lee JS
Biotechnol Bioeng; 2020 Jun; 117(6):1895-1903. PubMed ID: 32086804
[TBL] [Abstract][Full Text] [Related]
17. Improved recombinant antibody production by CHO cells using a production enhancer DNA element with repeated transgene integration at a predetermined chromosomal site.
Kawabe Y; Inao T; Komatsu S; Huang G; Ito A; Omasa T; Kamihira M
J Biosci Bioeng; 2017 Mar; 123(3):390-397. PubMed ID: 27856232
[TBL] [Abstract][Full Text] [Related]
18. A novel Bxb1 integrase RMCE system for high fidelity site-specific integration of mAb expression cassette in CHO Cells.
Inniss MC; Bandara K; Jusiak B; Lu TK; Weiss R; Wroblewska L; Zhang L
Biotechnol Bioeng; 2017 Aug; 114(8):1837-1846. PubMed ID: 28186334
[TBL] [Abstract][Full Text] [Related]
19. High-efficiency and multilocus targeted integration in CHO cells using CRISPR-mediated donor nicking and DNA repair inhibitors.
Hamaker NK; Lee KH
Biotechnol Bioeng; 2023 Sep; 120(9):2419-2440. PubMed ID: 37039773
[TBL] [Abstract][Full Text] [Related]
20. One-step generation of triple knockout CHO cell lines using CRISPR/Cas9 and fluorescent enrichment.
Grav LM; Lee JS; Gerling S; Kallehauge TB; Hansen AH; Kol S; Lee GM; Pedersen LE; Kildegaard HF
Biotechnol J; 2015 Sep; 10(9):1446-56. PubMed ID: 25864574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
